Special Issue "Aging and Drug Discovery"

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: 31 March 2020.

Special Issue Editor

Prof. Stuart Maudsley
E-Mail Website
Guest Editor
Universiteit Antwerpen, Antwerpen, Belgium

Special Issue Information

Dear Colleagues,

Across the world, premature mortality rates continue to drop, and while this trend should be welcomed, it also inculcates further healthcare issues, e.g., the global emergence of an aged population. Increasing age brings with it the increased socioeconomic burden of age-related diseases, e.g., cancer, cardiovascular disease, type II diabetes mellitus, chronic kidney disease, and dementia. This interesting scenario therefore presents several novel problems for the future of drug design and development, i.e., do we develop i) agents that can forestall the aging process, ii) therapies that are capable of clearing away aged/diseased cells, or iii) precision agents capable of controlling the symptoms of these diseases in an elderly individual? In the future, it is likely that all of these potential strategies will be exploited to reduce the prevalence of age-related disease. In this Special Issue of Pharmaceuticals, we will explore the most exciting and innovative advances in molecular gerontology and pharmacology.

Prof. Stuart Maudsley
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • aging
  • gerontology
  • pharmacology
  • senescence
  • resilience
  • therapeutic

Published Papers

This special issue is now open for submission.
Back to TopTop